Oculis Holding AG (OCS) Payables (2021 - 2026)

Oculis Holding AG's (OCS) quarterly Payables came in at $5.7 million in Q1 2026, up 18.64% year-on-year from $4.8 million in Q1 2025, and up 154.94% quarter-over-quarter from $2.3 million in Q4 2025.

Oculis Holding AG (OCS) Payables (2021 - 2026) Analysis & Trends

Oculis Holding AG's Payables history runs 6 years deep, the most recent figure standing at $5.7 million for Q1 2026.

  • On a quarterly basis, Payables rose 18.64% year-over-year to $5.7 million in Q1 2026; TTM through Mar 2026 was $5.7 million, a 18.64% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, down 67.47% from the prior year.
  • Payables grew to $5.7 million in Q1 2026 per OCS's latest filing, from $2.3 million in the prior quarter.
  • Across five years, Payables topped out at $8.6 million in Q4 2023 and bottomed at $1.3 million in Q1 2024.
  • The 5-year median for Payables is $4.4 million (2023), against an average of $4.4 million.
  • Across the five-year window, Payables surged 349.18% in 2022 and slumped 72.97% in 2025, its largest moves.
  • Year by year, Payables stood at $4.0 million in 2022, then surged by 113.34% to $8.6 million in 2023, then declined by 21.74% to $6.7 million in 2024, then slumped by 66.4% to $2.3 million in 2025, then jumped by 154.94% to $5.7 million in 2026.
  • Per Business Quant, the three latest OCS Payables figures stand at $5.7 million (Q1 2026), $2.3 million (Q4 2025), and $1.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 5.74 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 10.62 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 8.69 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 423.55 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 489.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 1.03 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 80.54 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 126.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.74 Mn
Dec 31, 2025 2.25 Mn
Sep 30, 2025 1.53 Mn
Jun 30, 2025 1.45 Mn
Mar 31, 2025 4.84 Mn
Dec 31, 2024 6.70 Mn
Sep 30, 2024 5.65 Mn
Jun 30, 2024 3.52 Mn
Mar 31, 2024 1.35 Mn
Dec 31, 2023 8.56 Mn
Sep 30, 2023 7.60 Mn
Jun 30, 2023 4.36 Mn
Dec 31, 2022 4.01 Mn
Dec 31, 2021 893,629.73